Market Research Logo

Global Biopreservation Market - Segmented by Products, Services, Biospecimens, Application, End-users, and Geography - Growth, Trends, and Forecast (2018 - 2023)

Global Biopreservation Market - Segmented by Products, Services, Biospecimens, Application, End-users, and Geography - Growth, Trends, and Forecast (2018 - 2023)

The global biopreservation market accounted for a value of USD 2,406 million in 2017 and is estimated to grow at a CAGR of about 8.3%, during the forecast period. Biopreservation is defined as the extension of shelf life and improved safety of foods, by using the natural or controlled microbiota or antimicrobial compounds. It is an innocuous and ecological method to deal with the problem of food preservation and has gained increasing attention in the recent years.

Improving Healthcare Expenditure

Healthcare spending continues to rise faster than the economic growth in most countries, maintaining a trend that has been observed over decades. The presence of equitable, responsive, and efficient health systems across North America, Europe, UK, and Asia-Pacific, has also contributed to the maximum share of GDP that is being utilized in healthcare expenditure. In 2009, the United States had the highest health expenditure per capita (approximately USD 7,960), and a similar trend was also recorded in 2015. Countries like Norway and Switzerland were also the next big spenders on health, per capita. And with growing technological advancements in biopreservation and healthcare equipment, along with the cost-effectiveness of these instruments, a major share of healthcare spending is going to be in this domain. Factors like increasing life-expectancy and increasing patients with communicable and non-communicable diseases are major factors that have contributed to the growth of the market.
And the other factors, such as increasing advancements in R&D, adoption of in-house sample storage in hospitals and labs, and investments in biobanks and personalized medicine are increasing the growth of the biopreservation market.

High Cost of the Instruments and its Maintenance

Biopreservation facilities require highly sophisticated equipment and instruments to maintain samples at constant temperatures. These sophisticated equipment and instruments are expensive, and their high cost is a major restraint for the growth of the global biopreservation market. Systems from top companies start around USD 1 million and can hold between 250,000 and 10 million samples. Researchers may use laboratory information-management systems to search for appropriate samples for a particular study, such as those from donors of a particular age or weight, and then transmit their request to be retrieved. Few companies also sell automated freezers and data-management software for storing and tracking samples. The infrastructure required for a start up in its first year would probably cost between USD 3 million and 5 million, not including information systems. Operating costs for ten years could be more than USD 10 million. Obtaining funds for maintenance and ongoing expenses is also a major challenge. All these issues are hindering the market. The other factors, such as the possibility of tissue injury during preservation and thawing, are hindering the market growth.

Asia-Pacific is expected to Record a Substantial Growth

North America is dominating the biopreservation market due to novel drug developments and therapies in the biomedical research, in this region, and along it, the population that requires diagnosis and treatment of acute and chronic diseases is increasing. Asia-Pacific is expected to record a substantial growth over the forecast period.

Key Developments in the Market

February 2018: BioLife Solutions executed OEM Agreement with MilliporeSigma.
July 2017: Cesca Therapeutics acquired the cell processing systems of SynGen.


Reasons to Purchase the Report

Current and future market outlook for biopreservation in the developed and emerging markets
Analyze various perspectives of the market, with the help of Porter’s five forces analysis
The segment that is expected to dominate the market
Regions that are expected to witness the fastest growth, during the forecast period
Identify the latest developments, market shares, and strategies employed by the major market players.
3-month analyst support, along with the market estimate sheet (in excel).

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.

1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Products and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Improving Healthcare Expenditure
6.1.2 Increasing Advancements in R&D
6.1.3 Adoption of In-House Sample Storage in Hospitals and Labs
6.1.4 Investments in Biobanks and Personalized Medicine
6.1.5 Increased Adoption of Advanced Technologies, Like Asissted Reproductive Technology, Stem Cell Therapies, and Regenerative Medicines
6.2 Market Restraints
6.2.1 High Cost of the Instruments and its Maintenance
6.2.2 Possibility of Tissue Injury During Preservation and Thawing
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 Segmentation -By Products
7.1.1 Biopreservation Media Nutrient Media Sera Other Supplements
7.1.2 Equipment Temperature Maintaining Units Freezers Cryogenic Storage Systems Thawing Equipment Refrigerators Centrifuges Others
7.2 Segmentation -By Services
7.2.1 Biobanking for Individuals Umbilical Cord/Stem Cell Banking Ovum/ Egg Banking Sperm Banking
7.2.2 Biobanking for Institutions Tissue Banking Cell Banking Service Organ Banking Repository Services
7.3 Segmentation -By Biospecimens
7.3.1 Human Tissue Samples
7.3.2 Stem Cells
7.3.3 Organs
7.3.4 Other Biospecimens
7.4 Segmentation -By Application
7.4.1 Therapeutics
7.4.2 Research
7.4.3 Clinical Trials
7.4.4 Others
7.5 Segmentation -By End-users
7.5.1 Biobanks
7.5.2 Gene Bank
7.5.3 Hospitals
7.5.4 Others
7.6 Segmentation - By Geography
7.6.1 North America United States Canada Mexico
7.6.2 Europe France Germany United Kingdom Italy Spain Rest of Europe
7.6.3 Asia-Pacific China Japan India Australia New Zealand South Korea Rest of Asia-Pacific
7.6.4 Middle East & Africa GCC South Africa Rest of Middle East & Africa
7.6.5 South America Brazil Argentina Rest of South America
8. Competitive Landscape
8.1 Mergers and Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Product Launches
9. Key Players
9.1 BioLife Solutions Inc.
9.2 Cesca Therapeutics Inc.
9.3 Lifeline Scientific Inc.
9.4 Sigma-Aldrich Corporation
9.5 Thermo Fisher Scientific Inc.
9.6 BioCision LLC
9.7 Custom Biogenic Systems Inc.
9.8 Core Dynamics Ltd
9.9 Princeton CryoTech Inc.
9.10 VWR International
9.11 Others
10. Future of the Market

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report